IDStewardship

MARCH 23, 2023

In this article three infectious diseases pharmacists discuss the cross-roads of antimicrobial resistance and microbiology laboratory, reflecting on a recent Twitter chat on the topic. Patrick McDaneld, PharmD, BCIDP, Medical Science Liaison, Clinical Infectious Diseases, bioMérieux Brian Raux, PharmD, BCIDP, Medical Science Liaison, Clinical Infectious Diseases, bioMérieux Katherine Perez, PharmD, BCPS-AQ ID, Director, Antimicrobial Stewardship, bioMérieux Article Posted 24 March 2023 Active co

Hospitals 223

Hospitals Communication Patient Care 223

PharmaVoice

MARCH 20, 2023

Fungal infections are a growing challenge for hospitalized patients, and new treatments are badly needed.

Hospitals 122

Hospitals 122

Fierce Pharma

MARCH 22, 2023

AbbVie's blockbuster-to-be Parkinson's combo hits a wall as FDA questions delivery pump aliu Wed, 03/22/2023 - 11:17

FDA 133

FDA 133

PhRMA

MARCH 23, 2023

Last month marked the one-year anniversary of the reignited Cancer Moonshot, the White House’s ambitious goal of reducing the death rate from cancer by at least 50% over the next 25 years. Much of the positive trends in declining cancer mortality, down 33% since peaking in 1991, is driven in large part by innovative medicines researched and developed by America’s biopharmaceutical companies.

291

291

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

MARCH 23, 2023

The proposed legislation, sponsored by Chuck Grassley and Maria Cantwell, aims to necessitate transparency from PBMs.

187

187

STAT

MARCH 24, 2023

I am by no means telepsychiatry’s biggest fan. But since March 2020, when my practice of outpatient psychiatry changed overnight, I have adapted to it. I have learned to get up between appointments so I don’t sit in front of a computer all day and how to fit in patient visits while on a work trip. I still prefer being in the actual room with a patient, but I accept this is the way my job looks now.

145

145

PhRMA

MARCH 22, 2023

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.

231

231

Drug Topics

MARCH 23, 2023

Crunching the numbers can help pharmacies stay on top of their inventory.

187

187

STAT

MARCH 23, 2023

On Thursday, the Centers for Disease Control and Prevention announced another increase in the prevalence of autism among children. In a pair of new reports — one focused on 8-year-olds and one on 4-year-olds — the CDC found that 1 out of every 36 children has autism. This is a significant increase from the 2021 estimate of 1 in 44 , which was a big jump from 1 in 110 in 2006.

145

145

Fierce Healthcare

MARCH 21, 2023

Cleveland Clinic, IBM unveil first quantum computer dedicated to biomedical research hlandi Tue, 03/21/2023 - 11:49

145

145

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PhRMA

MARCH 20, 2023

Three years ago, amidst an unprecedented public health crisis, biopharmaceutical industry made a commitment to fight COVID-19. Leveraging decades of research and investments in emerging technologies and scientific expertise, we dedicated ourselves to finding medical solutions to prevent, diagnose and treat those impacted by the coronavirus.

Vaccines 222

Vaccines 222

Drug Topics

MARCH 20, 2023

The CGM provides accurate readings over 10.5 days of continuous wear.

187

187

European Pharmaceutical Review

MARCH 21, 2023

Primary overall survival (OS) analysis results from Kite’s Phase III ZUMA-7 study showed a statistically significant improvement for CAR T-cell therapy Yescarta ® in OS versus historical treatment. Yescarta demonstrated a 2.5-fold increase in patients who were alive at two years and did not experience cancer progression or require the need for additional cancer treatment compared to standard of care (SOC).

Chemotherapy 145

Chemotherapy 145

STAT

MARCH 22, 2023

The ongoing Marburg fever outbreak in Equatorial Guinea is significantly larger than has previously been acknowledged, according to new information released Wednesday by the World Health Organization, which warned there may be undetected chains of transmission of the deadly virus in the West African country. The update, the first in nearly a month, shows that the number of confirmed and probable cases has grown from nine to 29, with cases having been reported in three different provinces over a

144

144

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PhRMA

MARCH 21, 2023

The White House’s Office of Science and Technology Policy (OSTP) recently solicited stakeholder feedback on the clinical research infrastructure for emergency clinical trials, for which PhRMA submitted comments. PhRMA shares OSTP’s recognition of the importance of having a clinical trial infrastructure that supports sites that are ready to respond to emergency situations like COVID-19.

219

219

Drug Topics

MARCH 20, 2023

Stipulations of the settlements include data reporting, annual training, and an independent compliance officer.

Independent Pharmacies 187

Independent Pharmacies 187

Fierce Healthcare

MARCH 23, 2023

Taxpayers shouldn't foot the bill for health systems' massive 2022 investment losses, health economists say dmuoio Thu, 03/23/2023 - 17:25

133

133

STAT

MARCH 23, 2023

Early in the Covid-19 pandemic, new diagnoses of tuberculosis dropped like a stone in the United States. Data released Thursday by the Centers for Disease Control and Prevention suggest the pandemic effect has pretty much worn off; TB is nearly back to pre-2020 levels. “We’re getting … close to where we were pre-pandemic; not quite back yet with increases in cases in the last two years,” Philip LoBue, director of the CDC’s division of tuberculosis elimination,

134

134

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PhRMA

MARCH 20, 2023

The U.S. Census Bureau and the U.S. Bureau of Economic Analysis recently published annual trade data indicating that U.S. exports of goods exceeded $2 trillion in 2022. According to the report, U.S. exports of pharmaceutical preparations exceeded $90 billion in 2022 — an increase of $7 billion over the previous year. Recent PhRMA comments to the U.S.

200

200

Drug Topics

MARCH 20, 2023

According to 2 conference abstracts, CGM’s are effective in treating T2D and chronic kidney disease, but more data may be required to complete the picture.

Hospitals 187

Hospitals 187

European Pharmaceutical Review

MARCH 22, 2023

In a recent video , pharmaceutical microbiology expert Tim Sandle highlighted areas of concern and attention relating to mycological contamination control in manufacturing. Pharmaceutical product recalls due to fungal contamination have been increasing. These, together with environmental monitoring trend data, highlight several fungal contamination issues associated with pharmaceutical cleanrooms , cold rooms and other controlled areas.

133

133

STAT

MARCH 21, 2023

Africa is grappling with not one, but two outbreaks of Marburg fever, a disease that causes symptoms and a death rate comparable to Ebola, its viral cousin. Health officials in Tanzania announced Tuesday that they had confirmed the country’s first-ever Marburg outbreak, involving at least eight people so far, five of whom have died. One of the people who died is a health care worker.

133

133

Fierce Healthcare

MARCH 21, 2023

DOJ, state AGs drop appeal to UnitedHealth-Change Healthcare deal ruling pminemyer Tue, 03/21/2023 - 17:26

130

130

Drug Topics

MARCH 20, 2023

The company also will establish a $35 out-of-pocket price cap for for all patients with commercial insurance that use Latnus

Insurance 187

Insurance 187

Fierce Pharma

MARCH 22, 2023

US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi fkansteiner Wed, 03/22/2023 - 09:50

124

124

STAT

MARCH 20, 2023

This is part of a series about new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution. The rise of childhood obesity in the United States did not happen quickly. But, to medicine, “it sort of cropped up overnight,” says Bob Siegel, a pediatric obesity specialist at Cincinnati Children’s.

133

133

Fierce Healthcare

MARCH 24, 2023

Instacart reaches deal with Boston Children's to help deliver nutritious meals to patients rking Fri, 03/24/2023 - 15:18

128

128

Drug Topics

MARCH 22, 2023

The drug, called Lumisight, is an optical imaging agent that detects cancerous tissue during initial lumpectomy to allow for a more complete resection. An NDA has been submitted to the FDA.

FDA 186

FDA 186

Fierce Pharma

MARCH 22, 2023

Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD kdunleavy Thu, 03/23/2023 - 01:37

122

122

STAT

MARCH 20, 2023

In the emergency room today, everyone is suffering. Many emergency medicine physicians are struggling to provide quality care amid staffing shortages, increased pressure to meet productivity metrics, and frustrated patients battling prolonged wait times. Their situation is compounded by a sense that they have been abandoned by hospital leadership, leading to increasing levels of physician burnout and attrition.

Compounding 120

Compounding Hospitals 120

Fierce Healthcare

MARCH 21, 2023

CMS ruling paves way for virtual reality companies to obtain reimbursement from payers fdiamond Tue, 03/21/2023 - 15:53

128

128

Drug Topics

MARCH 21, 2023

Out of an abundance of caution, the infant formula giant has recalled one of their powdered infant formula products because of a potentially dangerous bacteria.

185

185

Fierce Pharma

MARCH 24, 2023

GSK plays defense after California judge approves plaintiff's expert testimony in high-stakes Zantac trial fkansteiner Fri, 03/24/2023 - 10:05

119

119